Business

InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12

Management to host conference call and webcast at 8:30am EDT TEL AVIV, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR),

articleInspiremd Inc.May 5, 20203/company/inspiremd-inc/news/inspiremd-to-report-first-quarter-2020-financial-results-and-provide-business-update-on-tuesday-may-12
InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12

About this update from Inspiremd Inc.

[{"type":"text","content":"Management to host conference call and webcast at 8:30am EDT\nTEL AVIV, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that management will host a conference call and webcast on Tuesday, May 12, 2020, to discuss financial results for the first quarter ended March 31, 2020, and provide a corporate update.\n Conference Call & Webcast:Tuesday, May 12th @ 8:30am EDTWithin the US: 877-451-6152Outside the US:201-389-0879Conference ID:13703268Webcast:http://public.viavid.com/index.php?id=139696 About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes. InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbols NSPR.WS and NSPR.WSB. Investor Contacts:Craig ShoreChief Financial OfficerInspireMD, [email protected] Jeremy FefferLifeSci Advisors, [email protected] \n\n\nSource: InspireMD, Inc.","length":3650,"tagName":"div"}]

More updates from Inspiremd Inc.